Kunming Zhenhua Pharmaceutical

Kunming Zhenhua Pharmaceutical is a specialized pharmaceutical manufacturer based in Kunming, China, and operates as a core subsidiary of KPC Pharmaceuticals (Kunming Pharmaceutical Group). The company is internationally recognized for its historic role in the industrialization of artemisinin, being the first manufacturer to extract and produce this essential antimalarial compound at scale. Its primary business focuses on the production of artemisinin derivatives, including artemether and artesunate, which are vital components of World Health Organization-recommended Artemisinin-based Combination Therapies (ACTs). In addition to its antimalarial portfolio, the company manufactures various chemical preparations and Traditional Chinese Medicines (TCM). Kunming Zhenhua maintains high-standard GMP manufacturing facilities and serves as a critical supplier for global health initiatives combating malaria in Africa and Southeast Asia.